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INTRODUCTION 
Sickle-cell disease (SCD) is a clinically heterogeneous autosomal recessive monogenic chronic 
anaemia characterized by recurrent episodes of severe vaso-occlusion, haemolysis and infection. 
Painful crises are the major SCD clinical manifestation probably due to significant increase in 
dense red blood cells (RBC) and reduction of their ability to pass through capillaries. Using 
proteomic strategies, we aim to discover  novel and better SCD prognosis biomarkers as early 
predictors of the transition from steady-state to crisis namely vaso-occlusive episodes, thus, 
allowing a prompt and specific therapeutic intervention. 
MATERIAL & METHODS 
Plasma and RBC were isolated from peripheral blood of SCD (SS) patients in steady-state or 
undergoing a vaso-occlusive episode (n=12). Plasma samples were depleted of the 14 most 
abundant proteins using the MARS-14 and RBC were fractionated into membrane and soluble 
fractions, the latter being depleted of haemoglobin using HemovoidTM. Depleted plasma and 
soluble RBC samples were labelled with alternative fluorescent dyes (Lumiproble 3DyeTM 2D 
DIGE kit) and separated by 2DE using 24cm IPG strips (pH 4-7 and 3-10NL, respectively). 
After 2nd dimension, images were acquired in a Typhoon Variable Mode Imager and analysed 
by Progenesis SameSpots software. Differentially expressed spots were excised from 
Coomassie-stained preparative gels and proteins identified by MALDI-TOF/TOF MS.   
RESULTS & CONCLUSION 
Prior to use, the efficiency of Lumiproble fluorescent dyes was assessed in comparison 
with GE Healthcare and Ramidus Dye systems. The Lumiproble Dye system showed better 
results with less overlay between the emission spectra of these dyes when compared with 
the others. The 2D-maps analysis showed differentially expressed spots across the 
different groups/samples in the study. The proteins identified by MS were annotated 
according to molecular function and associated pathways to disclose altered 
mechanisms related with SCD. The complete characterization and validation of these 
differently expressed proteins are in progress and may constitute a specific biosignature 
of steady-state to crisis transition in SCD.  
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